Please try another search
For the three months ended 31 March 2022, Pharmicell Co Ltd revenues increased 43% to W17.42B. Net income increased from W1.89B to W4.93B. Revenues reflect Chemical segment increase of 42% to W16.85B, BIO-Business segment increase of 78% to W572.5M, United States segment increase from W3.37B to W7.14B, South Korea segment increase of 56% to W8.49B. Net income benefited from Chemical segment income increase of 88% to W6.31B.
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 17419.62 | 11797.08 | 13174.88 | 13765.52 |
Gross Profit | 8185.64 | 5586.79 | 6361.52 | 5948.26 |
Operating Income | 4908.71 | -587.3 | 3399.98 | 3392.68 |
Net Income | 4929.91 | 1870.18 | 3575.47 | 2173.62 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 103593.61 | 95814.78 | 97841.35 | 94051.63 |
Total Liabilities | 28906.34 | 30461.55 | 33092.98 | 32878.72 |
Total Equity | 74687.28 | 65353.23 | 64748.38 | 61172.9 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 0 Months | 9 Months | 6 Months |
Cash From Operating Activities | 4669.66 | -5222.2 | 6082.93 | 2465.3 |
Cash From Investing Activities | -2874.96 | -9345.1 | -8352.46 | -7471.78 |
Cash From Financing Activities | -67.53 | 18512.49 | 18907.38 | 18923.4 |
Net Change in Cash | 2003.83 | 5272.47 | 17942.96 | 14377.33 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review